FDA reverses two decades of guidance on hormone replacement therapy

The Food and Drug Administration has removed the boxed warnings from the labeling for all hormones used in treating menopausal symptoms. The removal of these warnings has been controversial. Understanding the background leading to these changes can assist nurses in counseling women.